Advocates For Oral Contraceptive Switch Shop For Pharma Partner
This article was originally published in The Pink Sheet Daily
Executive Summary
A Center for Reproductive Rights report acknowledges work by the Oral Contraceptives Over-the-Counter Working Group, which is positioned to partner on a switch NDA through a $12m grant, and looks comprehensively at the outlook for a daily-use oral contraceptive switch.
You may also be interested in...
Birth Control Primed For Switch
A new paradigm for nonprescription approvals could eliminate the risk of self-selecting a birth control drug, with some contraindications might likely not apparent, by having pharmacists provide counseling and screening or having women use a self-assessment tool with a standard algorithm.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.